IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors.
In the course of inflammatory responses in peripheral tissues, NK cells may be exposed to cytokines such as IL-12 and IL-4 released by other cell types that may influence their functional activities. In the present study we comparatively analyzed purified human peripheral blood NK cells that had been exposed to either IL-12 or IL-4 during short (overnight) incubation. We show that although IL-12-cultured NK cells produced abundant IFN-gamma, TNF-alpha, and GM-CSF in response to stimuli acting on the NKp46-activating receptor, IL-4-cultured NK cells did not release detectable levels of these cytokines. In contrast, IL-4-cultured NK cells produced significant levels of TNF-alpha and GM-CSF only when stimulated with PMA and ionomycin. In no instance could the production of IL-5 and IL-13 be detected. Importantly, IL-12-cultured, but not IL-4-cultured, NK cells displayed strong cytolytic activity against various tumor cells or immature dendritic cells (DCs). Moreover, only NK cells that had been cultured in IL-12 were able to induce substantial DC maturation. Our data suggest that NK cells exposed to IL-12 for a time interval compatible with in vivo responses may favor the selection of appropriate mature DCs for subsequent Th1 cell priming in secondary lymphoid organs. On the contrary, NK cells exposed to IL-4 do not exert DC selection, may impair efficient Th1 priming, and favor either tolerogenic or Th2-type responses.
Marcenaro
Emanuela
E
Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genova, Italy.
Della Chiesa
Mariella
M
Bellora
Francesca
F
Parolini
Silvia
S
Millo
Romano
R
Moretta
Lorenzo
L
Moretta
Alessandro
A
D002450:Cell Communication / Q000276:immunology*; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000502:physiology*; D006801:Humans; D007249:Inflammation; D018664:Interleukin-12 / Q000276:immunology* / Q000502:physiology; D015847:Interleukin-4 / Q000276:immunology* / Q000502:physiology; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000502:physiology*; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000473:pathology*; D018417:Th1 Cells; D018418:Th2 Cells
D016207:Cytokines; D018664:Interleukin-12; D015847:Interleukin-4